Viewing Study NCT02633436



Ignite Creation Date: 2024-05-06 @ 7:57 AM
Last Modification Date: 2024-10-26 @ 11:54 AM
Study NCT ID: NCT02633436
Status: UNKNOWN
Last Update Posted: 2016-08-12
First Post: 2015-12-06

Brief Title: Research on the Role of SLC1A5 in the Development of Esophageal Cancer
Sponsor: Fourth Affiliated Hospital of Guangxi Medical University
Organization: Fourth Affiliated Hospital of Guangxi Medical University

Study Overview

Official Title: Research on the Role of the Amino Acid Transporter SLC1A5 in the Development of Esophageal Cancer
Status: UNKNOWN
Status Verified Date: 2016-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To explore the significance of Solute Carrier Family 1 Member 5 SLC1A5 in the occurrence of esophageal cancer by comparing the expression of SLC1A5 between esophageal cancer tissues and adjacent tissues
Detailed Description: This will be an observational study The investigators will aim to enroll 100 male and female adult patients aged 18 years and over of all ethnicitiesraces who have been referred to the Fourth Affiliated Hospital of Guangxi Medical University for esophageal cancer

The investigators will be using a standardized data collection form This is an observational study in which standard of care will be practiced and the patients are not placed at additional risk from participating in this study However as the investigators are collecting data prospectively all participants will sign consent An attempt will be made to see if there is a correlation between the expression of SLC1A5 with esophageal cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None